XMU-MP-3
XMU-MP-3 is a potent non-covalent BTK inhibitor with IC50s of 10.7 nM and 17.0 nM for BTK WT and BTK C481S mutation in the presence of 10 μM ATP, respectively. XMU-MP-3 also induces apoptosis[1].
Product Specifications
CAS Number
2031152-08-4
UNSPSC
12352005
Target
Apoptosis; Btk
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xmu-mp-3.html
Purity
95.69
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C(C)C(N2CC3=CN=C(NC4=CC(C)=NN4C)N=C3N(C)C2)=C1)C5=CC=CC(C(F)(F)F)=C5
Molecular Formula
C27H27F3N8O
Molecular Weight
536.55
References & Citations
[1]Fu Gui, et al. A Non-Covalent Inhibitor XMU-MP-3 Overrides Ibrutinib-Resistant Btk C481S Mutation in B-cell Malignancies. Br J Pharmacol. 2019 Dec;176 (23) :4491-4509.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041604-500 1x 500 µL
CD4 (T-Helper/Inducer Cell Marker) (CD4/1604), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PKSV030363 100 µg
Recombinant SARS-CoV-2 Spike S1 (L18F, D80A, D215G, ΔLAL242-244, R246I, K417N, E484K, N501Y, D614G) (His Tag)
Sign In for Pricing
View Details